(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to [email protected]) ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than $7.

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...

Local governments began suing pharmaceutical companies such as Purdue Pharma in 2017. Brad Schimel was the state attorney ...

Third-party releases may no longer provide a shield to owners and directors of a reorganized company. Still, a New York bankruptcy court ...

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy bankruptcy case says.

The bankrupt drugmaker and OxyContin manufacturer will be dissolved and its assets transferred to a new company.

Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims by state and municipal governments and individuals.

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...

Purdue Pharma asked a bankruptcy judge this week to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that ...